The future of multiple sclerosis therapies : redesigning multiple sclerosis clinical trials in a new therapeutic era^aMCFARLAND, H. F; REINGOLD, S. C.Multiple sclerosis. 2005, Vol 11, Num 6, pp 669-676, issn 1352-4585, 8 p.Article

Impaired measles virus-specific cytotoxic T cell responses in multiple sclerosisJACOBSON, S; FLERLAGE, M. L; MCFARLAND, H. F et al.The Journal of experimental medicine. 1985, Vol 162, Num 3, pp 839-850, issn 0022-1007Article

Thalamic Involvement and Its Impact on Clinical Disability in Patients with Multiple Sclerosis: A Diffusion Tensor Imaging Study at 3TTOVAR-MOLL, F; EVANGELOU, I. E; BAGNATO, F et al.American journal of neuroradiology. 2009, Vol 30, Num 7, pp 1380-1386, issn 0195-6108, 7 p.Article

Differential diagnosis of suspected multiple sclerosis : a consensus approachMILLER, D. H; WEINSHENKER, B. G; KIRA, J et al.Multiple sclerosis. 2008, Vol 14, Num 9, pp 1157-1174, issn 1352-4585, 18 p.Article

Expression profiling identifies responder and non-responder phenotypes to interferon-β in multiple sclerosisSTÜRZEBECHER, S; WANDINGER, K. P; ROSENWALD, A et al.Brain. 2003, Vol 126, pp 1419-1429, issn 0006-8950, 11 p., 6Article

Longitudinal MRI study: The effects of azathioprine in MS patients refractory to interferon β-1bMARKOVIC-PLESE, S; BIELEKOVA, B; KADOM, N et al.Neurology. 2003, Vol 60, Num 11, pp 1849-1851, issn 0028-3878, 3 p.Article

FLAIR and magnetization transfer imaging of patients with post-treatment Lyme disease syndromeMORGEN, K; MARTIN, R; STONE, R. D et al.Neurology. 2001, Vol 57, Num 11, pp 1980-1985, issn 0028-3878Article

Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosisFILIPPI, M; HORSFIELD, M. A; PATY, D. W et al.Annals of neurology. 1998, Vol 43, Num 4, pp 499-506, issn 0364-5134Article

Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosisZIPP, F; WELLER, M; CALABRESI, P. A et al.Annals of neurology. 1998, Vol 43, Num 1, pp 116-120, issn 0364-5134Article

VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon betaCALABRESI, P. A; PELFREY, C. M; TRANQUILL, L. R et al.Neurology. 1997, Vol 49, Num 4, pp 1111-1116, issn 0028-3878Article

A novel candidate autoantigen in a multiplex family with multiple sclerosis : prevalence of T-lymphocytes specific for an MBP epitope unique to myelinationVOSKUHL, R. R; MCFARLIN, D. E; TRANQUILL, L. R et al.Journal of neuroimmunology. 1993, Vol 46, Num 1-2, pp 137-144, issn 0165-5728Article

Diversity in fine specificity and T cell receptor usage of the human CD4⁺ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106MARTIN, R; UTZ, U; COLIGAN, J. E et al.The Journal of immunology (1950). 1992, Vol 148, Num 5, pp 1359-1366, issn 0022-1767Article

Changes in leukocyte recirculation, NK cell activity, and HLA-DR expression in peripheral blood mononuclear cells of MS patients treated with poly ICLCBEVER, C. T; JACOBSON, S; MINGIOLI, E. S et al.International journal of immunopharmacology. 1991, Vol 13, Num 5, pp 613-618, issn 0192-0561Article

Humoral and cellular immune responses to matrix protein of measles virus in subacute sclerosing panencephalitisSUHAYL DHIB-JALBUT; MCFARLAND, H. F; MINGIOLI, E. S et al.Journal of virology. 1988, Vol 62, Num 7, pp 2483-2489, issn 0022-538XArticle

In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosisBAGNATO, F; BUTMAN, J. A; MCFARLAND, H. F et al.American journal of neuroradiology. 2006, Vol 27, Num 10, pp 2161-2167, issn 0195-6108, 7 p.Article

MRI as a marker for disease heterogeneity in multiple sclerosisBIELEKOVA, B; KADOM, N; MARTIN, R et al.Neurology. 2005, Vol 65, Num 7, pp 1071-1076, issn 0028-3878, 6 p.Article

Proton MR spectroscopic imaging in multiple sclerosisTEDESCHI, G; BONAVITA, S; MCFARLAND, H. F et al.Neuroradiology (Berlin. Print). 2002, Vol 44, Num 1, pp 37-42, issn 0028-3940Article

The role of MRI as a surrogate outcome measure in multiple sclerosisMCFARLAND, H. F; BARKHOF, F; ANTEL, J et al.Multiple sclerosis. 2002, Vol 8, Num 1, pp 40-51, issn 1352-4585Article

Ring-enhancement in multiple sclerosis : marker of disease severityMORGEN, K; JEFFRIES, N. O; STONE, R et al.Multiple sclerosis. 2001, Vol 7, Num 3, pp 167-171, issn 1352-4585Article

Analysis of gene expression in multiple sclerosis lesions using cDNA microarraysWHITNEY, L. W; BECKER, K. G; TRESSER, N. J et al.Annals of neurology. 1999, Vol 46, Num 3, pp 425-428, issn 0364-5134Conference Paper

Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with interferon beta-1bRICHERT, N. D; OSTUNI, J. L; BASH, C. N et al.American journal of neuroradiology. 1998, Vol 19, Num 9, pp 1705-1713, issn 0195-6108Article

Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in htlv-i-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-tacLEHKY, T. J; LEVIN, M. C; FLEISHER, T. A et al.Annals of neurology. 1998, Vol 44, Num 6, pp 942-947, issn 0364-5134Article

Experimental allergic encephalomyelitis induced by the peptide encoded by exon 2 of the MBP gene, a peptide implicated in remyelinationRAINE, C. S; MCFARLIN, D. E; VOSKUHL, R. R et al.Journal of neuroimmunology. 1994, Vol 51, Num 1, pp 7-19, issn 0165-5728Article

Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4⁺ T cells from multiple sclerosis patientsPELFREY, C. M; TROTTER, J. L; TRANQUILL, L. R et al.Journal of neuroimmunology. 1993, Vol 46, Num 1-2, pp 33-42, issn 0165-5728Article

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosisMCFARLAND, H. F; FRANK, J. A; ALBERT, P. S et al.Annals of neurology. 1992, Vol 32, Num 6, pp 758-766, issn 0364-5134Article